On day 2 after CLL or NaCl-L treatment, we analyzed the numbers of myeloid dendritic cells (mDCs; F480+CD11c+), lymphoid dendritic cells (lymDCs: F480−CD11c+), Kupffer cells (F480+CD11c−) and B cells (B220+) in the liver to determine the efficacy of pAPCs depletion. The gene discussed is PTPRC; the disease is B-cell chronic lymphocytic leukemia.